TxBench-PP tests AI agents on preclinical pharmacology

A June 18 arXiv cs.AI listing introduced TxBench-PP, a benchmark for analyzing AI-agent performance on small-molecule preclinical pharmacology. The paper is arXiv:2606.19245 and is cross-listed under Artificial Intelligence and Machine Learning. The benchmark focuses on pharmacology tasks rather than generic reasoning, connecting agent evaluation to drug-discovery and preclinical research workflows.

Key details: Listed on arXiv cs.AI on June 18, 2026, The paper is arXiv:2606.19245, The subject areas are Artificial Intelligence and Machine Learning, The title focuses on small-molecule preclinical pharmacology.

Why it matters: Domain-specific benchmarks like TxBench-PP can reveal whether AI agents are useful in biomedical research settings where generic reasoning scores are not enough.